Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

How a junior copper and gold explorer added the coveted Santa Cecilia project to its portfolio

The copper price has had a booming 2021 — having reached an all-time high of US$4.90 in May of this year — and companies in the space have been reaping the benefits of this year’s hottest metal. Meet Vancouver, BC-based Torq Resources Inc. ( TSXV:TORQ ,...

Shares Rise as The Medicines Company Reports Positive Topline Results...

Shares Rise as The Medicines Company Reports Positive Topline Results from Two Phase 3 Cholesterol Trials The Medicines Company's shares are trading 8.5% higher today after the firm reported positive results from two phase 3 studies for inclisiran, one for familial hype...

Myovant Sciences Shares Up 110% on Phase 3 Advanced Prostate Cancer Data

Shares of Myovant Sciences opened 120% higher today after the firm reported a 97% response rate in its Phase 3 HERO Study of oral Relugolix in men with advanced prostate cancer. In the study, Relugolix achieved all six key secondary endpoints and the firm expects to submit a N...

ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results

Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. After the U.S. markets closed yesterday, ChemoCentryx Inc. ...

Kodiak Shares Soar on $225 Million Royalty Deal for Retinal Drug

Shares of Kodiak Sciences traded more than 100% higher at times after the company reported that it entered into a $225 million royalty agreement for the firm's KSI-301 used in the treatment of retinal vascular diseases including age-related macular degeneration and diabetic ey...

Buzz on the Bullboards: Rebound, or smoke and mirrors?

Could the recent fears around banking stocks be washing away? Given the recent performance among major indices, it seems possible. Gold held steady as the usual investment haven and that played right into the hands of miners ready with fresh news. Reaping the fr...

Buzz on the Bullboards: new TSX highs, mining and consumer staples rally

The TSX closed higher for the sixth consecutive session on Wednesday, reaching a new record high, supported by strong performances in mining and consumer staples sectors. This sustained momentum reflects investor confidence in Canada’s resource-rich ...

Small-Cap Using AI Aims to Become the 'Uber of Recruiting'

This company is disrupting the recruiting industry by using advanced technology, such as artificial intelligence, to connect employers to its wide network of over 10,000 independent recruiters. With a tight job market, employers can struggle to find qualified t...

Buzz on the Bullboards: New Rising Opportunities

There has been a lot of attention on the tech sector and the stocks working in that marketplace as of late. Despite market volatility, the tech-heavy Nasdaq has displayed much growth this year as it dug itself out of the COVID hole that had investors and the markets at large p...

Buzz on the Bullboards: T’is the Season for a Rebound?

(Image via SweetWater Brewing Co.) It happens every year, the mood among North American markets changes drastically once American Thanksgiving passes and despite a “socially distanced” holiday this year, that still holds true. Traders are ...
1 2